Regeneron Pharmaceuticals, Inc. Cash Flow Statement

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2009	Dec2010	Dec2011	Dec2012	Dec2013	Dec2014	Dec2015	Dec2016	Dec2017	Dec2018	Dec2019	Dec2020	Dec2021	Dec2022	Dec2023	Dec2024
Operating Activities
Net Income	-0.07B	-0.10B	-0.22B	0.75B	0.41B	0.34B	0.64B	0.90B	1.20B	2.44B	2.12B	3.51B	8.08B	4.34B	3.95B	4.41B
Depreciation and Depletion							0.07B	0.10B	0.14B
Share-based Compensation	0.03B	0.04B	0.06B	0.09B	0.22B	0.32B	0.46B	0.56B	0.51B	0.43B	0.46B	0.43B	0.60B	0.72B	0.89B	0.98B
Deferred Taxes				0.34B	-0.06B	0.05B	0.12B	0.36B	-0.32B	0.14B	0.13B	-0.08B	0.15B	0.75B	0.84B	0.76B
Gains from Investment Securities		-0.00B	0.03B	0.16B	0.20B	0.27B	0.28B	0.48B	0.75B	0.21B	0.34B	0.68B	1.22B	1.50B	0.87B	1.03B
Non-cash Items	-0.00B	0.20B	0.08B	-0.82B	0.17B	0.41B	0.69B	0.59B	0.11B	-0.25B	0.31B	-0.90B	-0.99B	0.68B	0.64B	0.01B
Cash from Operations	-0.07B	0.10B	-0.14B	-0.07B	0.59B	0.75B	1.33B	1.49B	1.31B	2.20B	2.43B	2.62B	7.08B	5.01B	4.59B	4.42B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)	0.01B	0.02B	0.03B	0.04B	0.04B	0.05B	0.07B	0.10B	0.15B	0.15B	0.21B	0.24B	0.29B	0.34B	0.42B	0.48B
Change in Working Capital
Change in Receivables	0.03B	0.02B	0.02B	0.59B	0.25B	0.03B	0.49B	0.14B	0.36B	0.24B	0.52B	1.36B	1.93B	-0.71B	0.34B	0.55B
Change in Inventory			0.01B	0.03B	0.05B	0.06B	0.11B	0.15B	0.31B	0.39B	0.34B	0.53B	0.49B	0.70B	0.27B	0.62B
Change in Accured Expenses	0.01B	0.01B	0.05B	0.01B	0.14B	0.16B	0.30B	0.25B	-0.02B	0.06B	0.60B	0.12B	0.87B	-0.14B	0.60B	0.74B
Other Working Capital Changes	-0.03B	0.16B	-0.04B	-0.04B	-0.04B	0.05B	0.61B	0.24B	0.11B	0.09B	0.14B	0.15B	0.24B	0.15B	0.12B	0.41B
Investing Activities
Capital Expenditures	0.10B	0.10B	0.06B	0.05B	0.16B	0.33B	0.68B	0.51B	0.27B	0.38B	0.43B	0.61B	0.55B	0.59B	0.72B	0.76B
Sales of Property, Plant and Equipment																0.02B
Acquisitions														0.23B	0.05B	0.02B
Change in Acquisitions & Divestments	0.30B	0.27B	0.43B	0.44B	0.38B	0.48B	0.33B	0.27B	0.54B	0.78B	1.60B	3.79B	2.22B	5.55B	9.44B	15.03B
Cash from Investing Activities	0.00B	-0.44B	0.13B	-0.08B	-0.36B	-0.42B	-0.91B	-1.05B	-1.01B	-1.46B	-2.03B	-0.07B	-5.38B	-3.78B	-3.19B	-2.47B
Financing Activities
Other financing activities				0.00B	0.21B	0.44B	0.41B									-0.03B
Cash from Financing Activities	0.03B	0.24B	0.38B	-0.10B	0.07B	-0.22B	-0.26B	-0.70B	-0.02B	-0.08B	-0.25B	-1.97B	-1.01B	-1.01B	-1.79B	-2.20B
Additional items
Exchange Rate Effect															-0.00B	-0.00B
Change in Cash	-0.04B	-0.09B	0.37B	-0.25B	0.31B	0.11B	0.16B	-0.26B	0.28B	0.66B	0.15B	0.58B	0.69B	0.22B	-0.38B	-0.25B
Free Cash Flow	-0.17B	-0.00B	-0.20B	-0.12B	0.43B	0.42B	0.65B	0.97B	1.03B	1.81B	2.00B	2.00B	6.53B	4.42B	3.88B	3.66B
Net Cash Flow	-0.04B	-0.09B	0.37B	-0.25B	0.31B	0.11B	0.16B	-0.26B	0.28B	0.66B	0.15B	0.58B	0.69B	0.22B	-0.38B	-0.25B

Regeneron Pharmaceuticals, Inc. Cash Flow Statement

Create an account

Sign In

Reset Password

Get Pro for 60% off